2026 IN THE PIPELINE: ACCEPTED & UNDER REVIEW 

[Accepted] 

Youn, H.Y., Le, T.T., Tran, S.H., Kim, J.H., Bekele, T., Jeon, Y., Kang, S.W., Cha, K.H., Kim, Y., Kang, K., Jung, S.H., Kim, M.* (2026). Inhibition of HDAC4 nuclear translocation by the stilbenoid THSG prevents glucocorticoid-induced muscle atrophy. (Accepted)

Kang, T.*, Kim, M.*, Yoo, Y., Le, T.T., Park, G., Jung, Y., Jeong, H., Lee, W.B., Jung, S.H. (2026). Anti-Allergic Effects of Chamaecrista nomame Extract and Luteolin in an OVA-Induced Asthma Mouse Model. Phytother. Res. 0:1-12. (*co-first author, IF: 6.1, JCR: 7.2%)

Youn, H.Y., Park, S., Min, H., Nguyen, B.N., Kim, Y.H., Cha, K.H., Park, Y.T., Kwon, H.Y., Lee, C.*, Kim, M.* (2026). Micheliolide ameliorates colon cancer cachexia by modulating gut microbiota–immune signaling via Phocaeicola vulgatus enrichment. Microbiome. 12, 251. (*co-corresponding author, IF: 13.8, JCR: 4.7%) 

[Under Review & Submission] 

Dhond, V., Jung, H., Van, K.T., Nguyen, B.N., Woo, C., Kim, D.M., Yu, J., Youn, H.Y., Bekele, T., Kim, M.*, Si, J.* (2025). Postbiotic effects of Roseburia intestinalis improve gut–muscle axis function via microbiota-dependent mechanisms in aging. (In revision)

Bekele, T., Park, S., Jeong, H., Lee, C., Kim, M. (2025). Integrative transcriptomic analysis reveals Ahnak as a therapeutic target for Rg3-mediated muscle atrophy prevention. (In submission)

Ly, N.P., Le, T.T.*, Nguyen, B.N., Kim, J.H., Kim, H., Jeon, Y., Kim, Y., Kang, S.W., Song, D.G., Jung, S.H.*, Kim, M.* (2025). Myricone C, a novel neolignan from Myristica fragrans, induces ER stress-mediated apoptosis in gastric and colorectal cancer via ROCK inhibition. (In submission)

Bekele, T., Yang, N.I., Ko, H., Le, T.T., Le, C., Cha, K.H., Youn, H.Y., Kim, K.H., Jung, S.H.*, Kim, M.* (2025). Auraptene Attenuates Dexamethasone-Induced Muscle Atrophy via β-Hydroxybutyrate-Mediated Enhancement of Mitochondrial Biogenesis and Protein Synthesis. (In submission)

Kim, M.*, Huda, M.N., Youn, H.Y., Gertz, E.R., Bennett, B.J.* (2025). Dissecting Gene-Microbiome Interactions in Atherosclerosis using a Systems Genetics Approach in a Large-Scale Mouse Population. (In submission)

Nguyen, B.N., Youn, H.Y., Ko, H., Kim, J.H., Kang, S.W., Jung, S.H., Kim, M. (2025). Magnolol as a novel therapeutic agent for sarcopenia and cachexia: Mechanism of action involves ERα activation and gut microbiome modulation. (In preparation)